Xinmei Shen / SCMP — Tech:Chinese biotech firms move beyond individual drug licensing deals as sector transitions to global innovation leadershipInnoCare and peers increasingly str…

InnoCare and peers increasingly structure complex partnerships rather than simple licensing arrangements.